Greenwich Rx is voluntarily recalling specific lots of compounded sterile products nationwide due to a potential lack of sterility assurance, the company announced. The 503A compounding pharmacy said the recall includes some products it compounded for another pharmacy, Clove Rx.

The company said the concerns followed an inspection by the U.S. Food and Drug Administration and Greenwich Rx’s evaluation of the affected products. Use of a drug intended to be sterile that is not sterile could cause serious infections, which may be life threatening, according to the announcement. Greenwich Rx said it has identified no evidence of contamination in the recalled products and has received no reports of adverse events to date.

The affected products were dispensed nationwide between Aug. 10, 2026 and Sept. 21, 2026. The company posted a list of the products, their lot numbers, and their beyond-use dates at https://greenwichrx.org/news/general-recall-2026-11. The company said it is notifying affected customers by mail. It encouraged customers who received medications through Clove Rx to review the list and contact Sedgwick with questions about whether a product is included.

Consumers and clinics that have a recalled product should stop using it immediately and discard it, the announcement said. Guidance on safe disposal is available at FDA.gov/DrugDisposal. Customers can direct questions to Sedgwick at 888-243-5547 or GreenwichRx6588@sedgwick.com Monday through Friday, 8:00 a.m. to 5:00 p.m. Eastern Time. Consumers who experience any issues after taking or using the recalled drugs should contact a physician or other health care provider.

Adverse reactions or quality problems can be reported to the FDA’s MedWatch program online at www.fda.gov/medwatch/report.htm or by mail or fax using forms available at www.fda.gov/MedWatch/getforms.htm. The company said the recall is being conducted with the knowledge of the FDA.